Moleculin Biotech (MBRX) Tops Q3 EPS by 3c
Moleculin Biotech (NASDAQ: MBRX) reported Q3 EPS of ($0.19), $0.03 better than the analyst estimate of ($0.22).
For earnings history and earnings-related data on Moleculin Biotech (MBRX) click here.
Moleculin Biotech (NASDAQ: MBRX) reported Q3 EPS of ($0.19), $0.03 better than the analyst estimate of ($0.22).
For earnings history and earnings-related data on Moleculin Biotech (MBRX) click here.